Dedicated CPT Codes Implemented
New dedicated CPT codes for superficial radiotherapy effective Jan 1, 2026; management reports clearer reimbursement environment and increased market confidence, enabling broader adoption and simpler coding for dermatology SRT.
Substantial Reimbursement Increase
Per-fraction delivery code increased by approximately 300%, materially improving physician economics and contributing to stronger inquiry levels and pipeline development.
Product Shipments and Installations
Shipped 14 SRT systems in Q1 (10 direct sales, 4 Fair Deal / rental placements); total installed base approximately 965 systems globally; Q1 shipments matched Q4 levels and management expects quarter-over-quarter improvement.
Recurring and Utilization Momentum
Treatment volumes increased 8% year-over-year; 18 active FDA sites and 9 pending activations; management emphasizes growth of utilization-based revenue through FDA placements, rentals, service and software.
SensusLink Launch
SensusLink software is live and deployed in several accounts, intended to drive recurring software/service revenue, enable billing of radiation physics consult code, and share weekly reimbursement (example: ~$93.85/week per patient protocol).
Shift Toward Purchases and Improved Breakeven
Approximately 70% of systems shipped in Q1 were purchases versus FDA; average breakeven for customers is now ~2 patients per month, encouraging earlier ownership decisions.
Strong Balance Sheet
Cash of $18.3 million and no debt at quarter end, providing liquidity to execute the transition strategy and support commercial expansion.
Reduced Operating Expenses
Quarterly expense reductions year-over-year: G&A down to $2.0M from $2.2M, Selling & Marketing down to $1.7M from $2.2M, and R&D down to $1.6M from $2.6M, reflecting disciplined cost management.
Pipeline and Commercial Engagement
Strong lead generation from major dermatology conferences (including AAD) and increasing engagement from independent dermatology practices, group networks, hospital systems and private equity-backed platforms; launched Sensus Healthcare Financial Services to improve conversion with flexible financing.